Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane in Advanced or Recurrent Endometrial Carcinoma
2004-001103-35Phase 2Completed
- Sponsor
- Nordic Society of Gynaecological Oncology
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of exemestane in endometrial cancer (EC), sponsored by Nordic Society of Gynaecological Oncology. Primary endpoints: Objective response rate and Response rate. Started Jan 2007; status: completed.
02
Drugs
exemestane
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on 2004-001103-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001103-35.